Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (14 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue from collaborations
46
53
35
24
Research and development
32
36
26
23
General and administrative
8
10
10
28
Total expenses
39
46
36
51
Income (loss) from operations
7
7
0
-27
Interest income
0
0
1
1
Interest expense
0
0
0
0
Other income (expense), net
0
0
0
0
Total other income, net
0
0
1
1
Income (loss) before income tax
7
7
0
-25
Income tax benefit (expense)
-3
-3
-2
0
Net Income (Loss)
4
4
-2
-26
Net income attributable to participating securities
3
3
0
0
Net income (loss) attributable to common shareholders
1
1
-2
-26
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (28 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
14
19
5
Investments
n/a
15
85
107
Accounts receivable from collaborations
n/a
10
5
6
Deferred tax asset
n/a
1
0
0
Prepaid expenses and other current assets
n/a
2
3
2
Total current assets
n/a
42
112
120
Property and equipment, net
n/a
1
1
1
Long-term investments
n/a
3
84
55
Long-term deferred tax asset
n/a
1
0
0
Deferred offering costs
n/a
6
0
0
Other assets
n/a
0
0
0
Total assets
n/a
54
197
176
Liabilities and owners' equity
Current maturities of contingently convertible debt, related party
n/a
12 12000000
0 0
0 0
Accounts payable
n/a
1 754000
0 441000
0 207000
Accrued liabilities
n/a
7 6579000
4 4176000
3 3138000
Accrued compensation
n/a
3 3269000
2 1683000
2 2457000
Deferred revenue from collaborations
n/a
0 0
6 6231000
2 2467000
Deferred rent and lease incentives
n/a
0 267000
0 25000
0 143000
Total current liabilities
n/a
23 22869000
13 12556000
8 8412000
Commitments and contingencies (Note 13)
n/a
0 0
0 0
0 0
Long-term deferred rent, lease incentives, and others
n/a
0 55000
0 47000
1 1104000
Total long-term liabilities
n/a
0 55000
0 47000
1 1104000
Common stock, no par value
n/a
4 3654000
187 186589000
192 191696000
Additional paid-in capital
n/a
3 2728000
4 3601000
6 6288000
Accumulated other comprehensive loss
n/a
0 -7000
0 -361000
-1 -575000
Accumulated deficit
n/a
-3 -3460000
-5 -5466000
-31 -30975000
Total shareholders’ equity
n/a
31 31124000
184 184363000
166 166434000
Total liabilities and shareholders’ equity
n/a
54 54048000
197 196966000
176 175950000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income (Loss)
4
4
-2
-26
Depreciation and amortization
0
1
1
0
Amortization of deferred financing costs
0
0
0
0
Stock-based compensation
1
1
1
9
Amortization net of premium/discount on marketable securities
0
0
1
2
Deferred taxes
2
2
2
0
Excess net tax provision related to share-based awards
0
0
0
0
Loss on disposal of fixed assets
0
0
0
0
Accounts receivable from collaborations
4
-2
5
-1
Prepaid expenses and other current assets
-1
0
0
1
Accounts payable
-2
0
0
0
Accrued liabilities
1
3
-2
-1
Accrued compensation
1
1
-2
1
Deferred rent and lease incentives
0
0
0
1
Deferred revenue from collaborations
1
-3
6
-4
Other assets
0
0
0
0
Net cash (used in) provided by operating activities
11
7
9
-17
Purchases of marketable securities available for sale
-16
-23
-202
-87
Maturities of marketable securities available for sale
12
17
49
91
Net additions to property and equipment
0
-1
0
0
Net cash provided by (used in) investing activities
-4
-7
-153
4
Repurchase of restricted stock units related to tax withholdings
0
0
0
-1
Proceeds from issuance of common stock
0
0
150
0
Restricted investments income
0
0
0
0
Sale of stock, net
0
0
0
0
Payments for deferred offering costs
-1
-3
-2
0
Excess tax benefit from stock-based compensation
0
0
0
0
Net cash (used in) provided by financing activities
-1
-3
148
-1
Increase (decrease) in cash and cash equivalents
7
-3
5
-14
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo